The mechanisms of EZH2 aberration and the molecular pathways involved in the regulation of EZH2 abundance and activity in human neoplasms together with the development of novel therapeutic opportunities to target EZH2 are under intense investigation. The gene discussed is EZH2; the disease is neoplasm.